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Abstract
Background: Prostatic acid phosphatase (PAP) and ecto-5’-nucleotidase (NT5E, CD73) produce extracellular
adenosine from the nucleotide AMP in spinal nociceptive (pain-sensing) circuits; however, it is currently unknown if
these are the main ectonucleotidases that generate adenosine or how rapidly they generate adenosine.
Results: We found that AMP hydrolysis, when measured histochemically, was nearly abolished in dorsal root
ganglia (DRG) neurons and lamina II of spinal cord from Pap/Nt5e double knockout (dKO) mice. Likewise, the
antinociceptive effects of AMP, when combined with nucleoside transport inhibitors (dipyridamole or 5-
iodotubericidin), were reduced by 80-100% in dKO mice. In addition, we used fast scan cyclic voltammetry (FSCV)
to measure adenosine production at subsecond resolution within lamina II. Adenosine was maximally produced
within seconds from AMP in wild-type (WT) mice but production was reduced >50% in dKO mice, indicating PAP
and NT5E rapidly generate adenosine in lamina II. Unexpectedly, we also detected spontaneous low frequency
adenosine transients in lamina II with FSCV. Adenosine transients were of short duration (<2 s) and were reduced
(>60%) in frequency in Pap-/-, Nt5e-/- and dKO mice, suggesting these ectonucleotidases rapidly hydrolyze
endogenously released nucleotides to adenosine. Field potential recordings in lamina II and behavioral studies
indicate that adenosine made by these enzymes acts through the adenosine A1 receptor to inhibit excitatory
neurotransmission and nociception.
Conclusions: Collectively, our experiments indicate that PAP and NT5E are the main ectonucleotidases that
generate adenosine in nociceptive circuits and indicate these enzymes transform pulsatile or sustained nucleotide
release into an inhibitory adenosinergic signal.
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Background
Neurons and glia throughout the nervous system release
adenosine 5’-triphosphate (ATP) spontaneously and in
response to diverse pathological insults, including tissue
damage, inflammation, hypoxia and nerve injury [1-4].
In the somatosensory system, ATP excites and sensitizes
nociceptive DRG neurons and can activate spinal micro-
glia [5]. The excitatory effects of extracellular ATP can
be terminated by a cascade of ectonucleotidases that
hydrolyze ATP to adenosine [6,7]. The speed at which
these ectonucleotidases work in any region of the ner-
vous system is unknown. Adenosine can signal through
the adenosine A1 receptor (A1R) to inhibit neurotrans-
mission and nociception [8,9].
Recently, we identified two ectonucleotidases in noci-
ceptive neurons that hydrolyze extracellular AMP to
adenosine. These enzymes include the transmembrane
isoform of prostatic acid phosphatase (PAP, also known
as ACPP) and ecto-5’-nucleotidase (NT5E). PAP and
NT5E are extensively co-localized in nociceptive DRG
neurons and on axon terminals located in lamina II of
the dorsal spinal cord [10,11]. PAP deficient (Pap-/-) and
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NT5E deficient (Nt5e-/-) mice have similar behavioral
phenotypes, including enhanced nociceptive sensitization
following nerve injury and following peripheral inflam-
mation. Mice lacking A1R likewise show enhanced sensi-
tization in models of chronic pain [12]. Humans with
null mutations in Nt5e develop very painful arterial cal-
cifications [13], suggesting loss of this adenosine-gener-
ating ectonucleotidase exacerbates an already painful
condition in humans [14]. While these and other data
suggest adenosine tonically inhibits nociceptive circuits
[15,16], the time frame over which adenosine is pro-
duced and the molecular source of adenosine (from
ectonucleotidases and/or directly released from cells) are
unknown [17].
Several studies suggest ectonucleotidases inhibit noci-
ception by generating adenosine from endogenously
released nucleotides. Notably, pharmacological inhibitors
of ectonucleotidases reduce adenosine production from
AMP in dorsal spinal cord and reduce adenosine release
in dorsal spinal cord synaptosomes [18,19]. Moreover,
AMP hydrolysis in spinal lamina II was reduced, but not
eliminated, in Pap-/- and Nt5e-/- single knockout mice
[10,11]. Lastly, intrathecal injection of soluble (non-
membrane bound) PAP or NT5E protein had long-last-
ing (2-3 days) antinociceptive effects that were entirely
dependent on A1R activation [11,20-22].
Here, we generated mice lacking PAP and NT5E to
investigate the combined importance of these enzymes
in nociceptive mechanisms. As part of this study, we
used FSCV to measure adenosine levels at subsecond
resolution in the spinal microdomain (lamina II) where
these enzymes are located [23,24]. Our data indicate
PAP and NT5E rapidly hydrolyze nucleotides to adeno-
sine and generate inhibitory adenosine transients in
spinal nociceptive circuits.
Results
PAP and NT5E are the main AMP ectonucleotidases in
spinal nociceptive circuits
Using enzyme histochemistry, we previously found that
AMP hydrolysis was reduced in DRG neurons and in
spinal lamina II of Pap-/- mice (at pH 5.6) and Nt5e-/-
mice (at pH 7.0) [10,11]. Since AMP hydrolysis was not
eliminated in either single knockout under any experi-
mental condition, this suggested both enzymes might
contribute additively to AMP hydrolysis. To test this
hypothesis, we bred Pap-/- and Nt5e-/- mice to generate
dKO mice. dKO mice were viable, had average sized lit-
ters and had no obvious physical abnormalities. We
then stained lumbar DRG and spinal cord sections from
WT, Pap-/-, Nt5e-/-, and dKO mice using AMP enzyme
histochemistry at neutral and acidic pH (Figure 1).
Staining intensity in lamina II was quantified through
image analysis. We found that small to medium
diameter DRG neurons, the epineurium surrounding
DRG, and nociceptive axon terminals in lamina II were
intensely stained in tissues taken from WT mice (Figure
1A, E, I, M). Staining was noticeably decreased in DRG
neurons and lamina II from Pap-/- mice at pH 5.6 (Fig-
ure 1J, N) and Nt5e-/- mice at pH 7.0 (Figure 1C, G),
while epineurium staining was eliminated in Nt5e-/-
mice at both pHs (Figure 1C, K). Strikingly, staining of
dKO DRG neurons was reduced at both pHs (Figure
1D, L) and nociceptive axon terminal staining in lamina
II was eliminated at both pHs in dKO mice (Figure 1H,
P). These findings suggest that PAP and NT5E are the
main enzymes that hydrolyze extracellular AMP in DRG
to spinal nociceptive circuits.
While these histochemical experiments at different
pHs allowed us to discriminate staining for PAP and
NT5E, a pH value of 5.6 may have limited physiological
relevance (although see Discussion). Thus, we next
sought to determine if PAP and NT5E were the main
AMP hydrolytic enzymes in vivo, using a behavioral
readout that is dependent on production of adenosine.
To accomplish this, we intrathecally (i.t.) injected mice
with AMP and dipyridamole (DIP) then measured ade-
nosine receptor-dependent changes in noxious thermal
sensitivity (Figure 2A). DIP is a nucleoside transport
inhibitor that allows extracellular adenosine to build up
and hence more effectively signal through adenosine
receptors [25]. When AMP (200 nmol) and DIP (5
nmol) were injected (i.t.) individually, neither drug
altered noxious thermal sensitivity in WT mice at 10, 30
or 1 hr post injection (data not shown). However, when
combined, AMP+DIP had a brief (10 min) but signifi-
cant thermal antinociceptive effect in WT mice (Figure
2B). This thermal antinociceptive effect was reduced by
54.7 ± 18.4% in Pap-/- mice, 44.2 ± 21.0% in Nt5e-/-
mice and eliminated (not significantly different from
baseline) in dKO mice. Moreover, AMP+DIP had no
antinociceptive effect in A1R
-/- mice, indicating this
behavioral effect was dependent on A1R activation.
To determine if these in vivo results could be repro-
duced with a different transport inhibitor, we co-
injected mice with AMP and 5-iodotubericidin (ITU)
(Figure 2A)–a drug that inhibits adenosine kinase and
nucleoside transporters at equivalent concentrations
[26]. AMP alone and ITU alone had no effect on ther-
mal sensitivity in mice [10]. However, these drugs (AMP
+ITU) had a 2 hr thermal antinociceptive effect when
co-injected (Figure 2C), consistent with a previous study
[10]. In addition, we found that the thermal antinocicep-
tive effect of AMP+ITU was reduced by 57.8 ± 8.2%
(percentage based on quantifying the area under the
curve relative to WT mice) in Nt5e-/- mice, 45.9 ± 8.0%
in Pap-/- mice and by 83.0 ± 5.1% in dKO mice (Figure
2C). We previously found that the thermal
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antinociceptive effect caused by AMP+ITU were fully
dependent on A1R activation [10]. Taken together, these
data with two different nucleoside transport inhibitors
provide compelling evidence that PAP and NT5E
account for the majority of all AMP hydrolytic activity
in spinal nociceptive circuits under physiologically rele-
vant in vivo conditions.
PAP and NT5E rapidly generate adenosine from AMP in
spinal lamina II
It is currently unknown how rapidly ectonucleotidases
generate adenosine in any tissue or cell of the body.
This lack of knowledge reflects technical limitations in
existing biochemical and biosensor based methods, all of
which sample adenosine levels over minutes to hours
[18,19,23,24,27]. And, enzyme histochemistry detects
inorganic phosphate following AMP hydrolysis, not ade-
nosine. As such, enzyme histochemistry is an indirect
way to measure adenosine production. Thus, to directly
quantify the speed and magnitude of adenosine produc-
tion in the anatomical microdomain where PAP and
NT5E are located (axon terminals in lamina II) we used
FSCV–an electrochemical technique that can detect ade-
nosine at subsecond resolution without interference
from metabolites (like inosine) [23]. This technique can
also distinguish adenosine from nucleotides (like ATP,
ADP, AMP) by an oxidation potential at 1.0 V that is
unique to adenosine. To perform these studies, we pres-
sure ejected AMP (100 μM) into lamina II of sagittal
spinal cord slices taken from WT, Pap-/-, Nt5e-/- and
Figure 1 AMP hydrolytic activity is reduced in DRG and spinal cord of Pap-/-, Nt5e-/-, and dKO mice. Lumbar (A-D, I-L) DRG and (E-H, M-P)
spinal cord sections from WT, Pap-/-, Nt5e-/-, and dKO mice were stained using AMP histochemistry at pH 7.0 or pH 5.6. Arrows (H and P) point
to lamina II. Staining intensity in lamina II was quantified from 7-10 sections per genotype as described (Methods) and reported (bottom left) as
means ± s.e.m. Repeated measures one-way ANOVA and Bonferroni’s post-hoc tests were used to compare staining intensity between
genotypes. At pH 7.0, staining intensity from Nt5e-/- and dKO slices were significantly decreased from WT (P < 0.0005), and at pH 5.6, Pap-/-,
Nt5e-/- and dKO were all significantly decreased from WT (Pap-/- and Nt5e-/-, P < 0.05; dKO, P < 0.0005). AMP concentration was 1 mM for DRG
and 6 mM for spinal cord sections. Similar results were obtained from n = 3 mice of each genotype. Scale bars: 50 μm (D and L), 200 μm (H and
P).
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dKO mice while measuring adenosine with a carbon-
fiber microelectrode (Figure 3A). Characteristic cyclic
voltammograms for adenosine with peaks at 1.0 and 1.5
V (Figure 3B; in vitro) were observed after AMP was
ejected into lamina II of WT slices (Figure 3B, C; in
slice) [23]. Moreover, the oxidation current at 1.0 V
peaked 2-3 s after the oxidation current at 1.5 V (Figure
3C), indicative of enzyme-dependent hydrolysis of AMP
to adenosine. The 1.0 V peak was not observed when
AMP was ejected into buffer, an agar block or outside
lamina II (data not shown), confirming the 1.0 V peak is
unique to adenosine.
In WT slices, adenosine levels peaked within ~4 s at a
concentration of 4.34 ± 0.57 μM at pH 7.4 (Figure 3C,
G). Adenosine production and peak levels (4.13 ± 0.55
μM) were not impaired in Pap-/- slices at pH 7.4 (Figure
3D, G, H), consistent with no visible reduction in AMP
hydrolysis at this pH (Figure 1F). However, adenosine
production and peak levels were significantly impaired
in Pap-/- slices at pH 5.6 compared to WT slices (0.72 ±
0.05 μM verses 1.66 ± 0.06 μM, respectively, Figure 3I,
J). In addition, adenosine production and peak levels
were significantly impaired in Nt5e-/- and dKO slices at
neutral and acidic pH (Figure 3E-J). Notably, peak ade-
nosine levels at pH 7.4 were significantly lower in dKO
slices than in Nt5e-/- slices (1.34 ± 0.11 μM verses 2.30
± 0.36 μM, respectively), unmasking a contribution of
PAP to adenosine production at neutral pH, similar to
histochemical studies with dKO tissues (Figure 1H).
Lastly, at pH 5.6, almost no adenosine was produced
after pressure ejecting AMP into lamina II of dKO slices
(Figure 3I, J). Taken together, these direct measures of
adenosine with gene knockout mice indicate that PAP
and NT5E rapidly generate adenosine at neutral and
acidic pH and together are the main adenosine-generat-
ing ectonucleotidases in spinal nociceptive circuits.
Remarkably, some adenosine was still produced in
dKO spinal slices at pH 7.4 (Figure 3H), suggesting
there is at least one more adenosine-generating enzyme
(see Discussion). The presence of this third enzyme
could not have been anticipated without first studying
Pap/Nt5e dKO mice.
Adenosine transients occur spontaneously and are
generated by PAP and NT5E
While performing FSCV studies, we unexpectedly
observed “adenosine transients"–spontaneous and transi-
ent increases in adenosine concentration–every time a
freshly-polished carbon-fiber microelectrode was placed
in lamina II of WT slices (Figure 4A). We also detected
transients in some, but not all, slices from Pap-/-, Nt5e-/-
, and dKO mice (Figure 4B-D). We did not see these
transients if microelectrodes were re-used without being
re-polished, suggesting debris on the tip interferes with
detection of these transients. The peaks at 1.0 V and 1.5
V in color plots and cyclic voltammograms (Figure 4)
confirmed that these transients contained adenosine.
Transient release was observed at a low frequency (0.35
Figure 2 The A1R dependent thermal antinociceptive effect of AMP, when combined with nucleoside transport inhibitors, is reduced
in Pap-/-, Nt5e-/-, and dKO mice. (A) AMP is hydrolyzed to adenosine by PAP and NT5E. Since adenosine is rapidly metabolized and transported
into cells, we found it was necessary to block the reuptake of adenosine with nucleoside transport (ENT) inhibitors (like ITU or DIP). This allowed
us to detect antinociceptive effects of adenosine under experimental conditions (behavior, field recordings). (B) Noxious thermal sensitivity was
measured before (baseline, BL) and after i.t. injection of AMP (200 nmol)+DIP (5 nmol). These drugs have no antinociceptive effects when
injected individually at these concentrations (not shown). A repeated measures two-way ANOVA was performed to compare all data sets (P <
0.0005 for WT, Pap-/- and Nt5e-/-), and Bonferroni’s post-hoc tests were performed to compare each genotype to baseline values at each time
point. (n = 8 mice per genotype). (C) Noxious thermal sensitivity was measured before (BL) and after i.t. injection of AMP (200 nmol)+ITU (5
nmol). These drugs have no antinociceptive effects when injected individually at these concentrations [10]. A repeated measures two-way
ANOVA was performed to compare data sets (P < 0.0005 for WT, Pap-/-, and Nt5e-/-), and Bonferroni’s post hoc-tests were performed to compare
each genotype to baseline at each time point. (n = 9-10 mice per genotype). A1R
-/- data in (C) replotted from [10]. (C-E) All data are presented as
means ± s.e.m. *P < 0.05, **P < 0.005, ***P < 0.0005.
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Figure 3 Adenosine production is impaired in spinal nociceptive circuits of Pap-/-, Nt5e-/- and dKO mice. FSCV was used to measure
adenosine production at subsecond resolution. (A) Illustration depicting the placement of the carbon fiber microelectrode and the micropipette
for pressure ejection of AMP into lamina II (transverse section shown to highlight anatomy; however, sagittal sections were used for these
experiments). (B) Normalized cyclic voltammograms obtained for adenosine in physiological buffer (in vitro, dashed trace) and during pressure
ejection of AMP into lamina II of a WT slice (solid trace; taken from the dashed vertical line in panel C). (C-F) Color plots for the 1 s pressure
ejection of 100 μM AMP into lamina II of (C) WT, (D) Pap-/-, (E) Nt5e-/-, and (F) dKO slices at pH 7.4. (G) Current extracted at 1.0 V from the
dashed horizontal lines in (C-F), converted to concentration of adenosine and plotted versus time. (H) Peak adenosine production following
pressure ejection of AMP into lamina II at pH 7.4 (n = 5 for each genotype). (I) Current extracted at 1.0 V from representative experiments
performed at pH 5.6. (J) Peak adenosine production following pressure ejection of AMP into lamina II at pH 5.6 (n = 5 for each genotype). (H, J)
One way ANOVAs with post-hoc tests were used to compare each genotype to WT and to compare between genotypes. *P < 0.05, **P < 0.005.
Data presented as means ± s.e.m.
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Figure 4 Spontaneous adenosine transients detected in lamina II by FSCV. (A-D) Concentration versus time traces (top) and color plots
(bottom) in slices (lamina II) from (A) WT, (B) Pap-/-, (C) Nt5e-/-, and (D) dKO mice. Scale bars are for the 1.0 V traces. (A-inset) Cyclic
voltammogram for the transient marked with an asterisk. Voltammograms had the signature shape for adenosine, as shown in Figure 3B. The
abrupt vertical lines in the color plots are due to a change in double-layer capacitance when fast events occur at the electrode surface, as seen
previously [56,57].
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± 0.04 events/min) in all WT slices (Table 1; with 2.5
mM extracellular calcium).
To ascertain if these events were Ca2+ dependent, we
chelated intracellular Ca2+ by pre-incubating slices in 10
μM BAPTA-AM for 45 minutes and removed extracellular
Ca2+ from the bath. Under these conditions, adenosine
transients were observed in four of the five slices, at a fre-
quency (0.06 ± 0.03 events/min) that was significantly less
than when calcium was present in the bath (Table 1). PAP
and NT5E do not require divalent cations for activity (see
histochemistry buffer in Methods), so this reduction was
not likely due to inhibition of PAP or NT5E.
Next, to determine if PAP and NT5E generate adeno-
sine transients, electrodes were placed into Pap-/-,
Nt5e-/-, and dKO slices and up to 20 consecutive one-
minute intervals were recorded, background subtracted
and corrected to account for background drift of the
electrode over time (Figure 5A, experiments with WT
slices were interleaved with knockout slices). Unlike WT
slices where transients were observed in every (19/19)
slice, spontaneous events were observed in a subset of
slices from Pap-/- (8/10 slices), Nt5e-/- (6/10 slices) and
dKO (9/16 slices) mice. Furthermore, in slices from
Pap-/-, Nt5e-/- and dKO mice where transients were
observed, the frequency was significantly lower than in
WT slices (Figure 5B). This reduction is unlikely to be
due to deficits in synaptic transmission since evoked
field excitatory postsynaptic potential (fEPSP) ampli-
tudes were not significantly different between WT and
mutant backgrounds (Figure 5C). Collectively, these
findings (summarized in Table 1) indicate PAP and
NT5E generate a majority of all adenosine transients,
presumably through hydrolysis of nucleotides that are
released by neurons and/or glia (see Discussion). More-
over, the observation that transient frequency can be
reduced in single and dKO mice suggests these transi-
ents can be dynamically modulated by manipulating
ectonucleotidase activity.
PAP and NT5E generate an A1R-dependent inhibitory
tone in nociceptive circuits
Adenosine has a tonic inhibitory effect on excitatory
neurotransmission in the spinal cord and brain
[6,15,16,28], although the molecular origins of this inhi-
bitory tone are unknown. Since PAP and NT5E rapidly
generate adenosine from nucleotides and deletion of
PAP and NT5E reduced the frequency of adenosine
transients, we hypothesized that PAP and NT5E might
generate the inhibitory adenosine tone in nociceptive
circuits. To test this hypothesis, we measured evoked
field excitatory postsynaptic potential (fEPSP) amplitude
in lamina II in the absence and presence of DIP with
the rationale that endogenously generated adenosine will
build up in the presence of DIP and inhibit excitatory
neurotransmission. Indeed, DIP significantly elevated
extracellular adenosine levels for an extended time per-
iod when AMP was pressure ejected into lamina II (Fig-
ure 6A, B), indicating DIP promotes the buildup of
ectonucleotidase-generated adenosine outside cells. In
the absence of DIP, dorsal root stimulation at very low
frequency (0.1 Hz) evoked a potential with rapid onset
and clearly discernable peak in WT and A1R
-/- slices
(Figure 7A, 7B1-B2, black trace), classified as an Aδ-fiber
waveform [29]. After application of DIP, this Aδ-fiber
fEPSP significantly decreased in amplitude from baseline
in WT slices but not in A1R
-/- slices (Figure 7B1-B3, red
trace).
To determine if this gradually developing A1R-depen-
dent inhibition was ectonucleotidase-dependent, we
tested slices from Pap-/-, Nt5e-/- and dKO mice (inter-
leaved with the WT and A1R
-/- slices above). While
fEPSP amplitude was equally reduced (inhibited) in
slices from WT, Pap-/- and Nt5e-/- mice following DIP
addition (Figure 7C1, C2, C4), fEPSP amplitude was not
significantly reduced when DIP was added to dKO slices
(Figure 7C3, C4). These results suggest that PAP and
NT5E individually generate sufficient amounts of adeno-
sine to inhibit excitatory neurotransmission; however,
when both enzymes are deleted, not enough adenosine
builds up over the time scale of these experiments to
significantly activate A1R and inhibit excitatory neuro-
transmission. Like the in vivo experiments with DIP and
ITU (where A1R activity is integrated over an extended
time period), these experiments revealed pronounced
deficits in dKO mice that were not apparent when PAP
or NT5E were individually deleted.
Table 1 Summary of adenosine transient events in spinal cord lamina II.
Genotype [Ca2+] (mM) [Ado]peak(nM) Frequency (events/min) Transient Time (s)
#
WT (n = 19) 2.5 570 ± 50 0.35 ± 0.04 1.5 ± 0.1
WT (n = 5) 0.0 410 ± 50 0.06 ± 0.03** 1.8 ± 0.3
Pap-/- (n = 10) 2.5 690 ± 150 0.14 ± 0.04* 1.5 ± 0.1
Nt5e-/- (n = 10) 2.5 360 ± 20 0.14 ± 0.07* 1.5 ± 0.1
dKO (n = 16) 2.5 380 ± 40 0.10 ± 0.03** 1.2 ± 0.1
Statistics: One-way ANOVA (P < 0.05) followed by Newman-Keuls multiple comparison post-hoc test to compare all genotypes relative to WT (2.5 mM Ca2+); *P <
0.05, **P < 0.005, ***P < 0.0005.
# Transient time was measured from the onset of the transient until the signal decayed to baseline.
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Nociception is enhanced in single and dKO mice
Noxious thermal and mechanical stimuli are sensed by
nociceptors that excite postsynaptic lamina II neurons
in spinal cord. Since the tonic inhibitory effects of ade-
nosine were impaired in lamina II of dKO mice, we
hypothesized that deletion of Pap and Nt5e might
enhance noxious thermal and/or mechanical sensitivity.
To test this hypothesis, we studied WT, Pap-/-, Nt5e-/-,
and dKO mice using behavioral models of acute and
chronic pain. We found that Pap-/-, Nt5e-/- and dKO
mice had no significant differences in mechanical
sensitivity (electronic Von Frey) and no significant dif-
ferences in two measures of noxious thermal sensitivity
(Hargreaves test and hotplate test at 52°C) (Table 2). At
a higher hotplate temperature (55°C), withdrawal latency
was significantly enhanced (shorter latency) in dKO
mice. All three mutant genotypes showed enhanced
thermal nociception in the tail immersion assay at 49.0°
C while Nt5e-/- and dKO mice showed enhanced ther-
mal nociception at 46.5°C. Likewise, thermal hyperalge-
sia and mechanical allodynia were significantly and
equally enhanced in Pap-/-, Nt5e-/- and dKO mice
Figure 5 Spontaneous adenosine transients in lamina II are reduced in frequency in Pap-/-, Nt5e-/- and dKO mice. (A) Representative
traces from each genotype showing adenosine concentration versus time, calculated from FSCV currents measured at 1.5 V. Traces were
background subtracted every 60 s and baseline corrected to compensate for electrode drift over time (which creates a visible 60 s oscillation in
the baseline). Raster plots below each trace mark each adenosine transient. Adenosine transients were considered to be events if the peak at 1.0
V was more than five times the standard deviation of the noise. (B) Adenosine transient frequency in WT (0.35 ± 0.04 events/min; n = 19 slices),
Pap-/- (0.14 ± 0.04 events/min; n = 10 slices), Nt5e-/- (0.14 ± 0.07 events/min; n = 10 slices), and dKO (0.11 ± 0.05 events/min; n = 16 slices) mice.
One-way ANOVAs with Bonferroni’s post-hoc tests were used to compare each genotype to WT and to compare between genotypes. *P < 0.05,
**P < 0.005. (C) Baseline fEPSP amplitude in WT, Pap-/-, Nt5e-/-, and dKO mice (n = 5/genotype). There were no significant differences between
WT and mutant mice. Data presented as means ± s.e.m.
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(relative to WT) following inflammation with complete
Freund’s adjuvant (CFA) (Figure 8A, B). Collectively,
these experiments with naïve (non-sensitized) and sensi-
tized animals suggest that PAP and NT5E tonically inhi-
bit nociception in vivo. Given that dKO mice showed
more pronounced physiological and behavioral deficits
when compared to single knockouts in several of the
experiments above, it is unclear why dKO mice did not
show more pronounced behavioral deficits in these
acute or chronic pain behavioral assays. Although as
previously discussed [10], this could reflect a number of
possibilities, with the most likely being biologically
imposed floor effects–mice may be unable to sense sti-
muli and/or withdrawal their paws any faster.
Discussion
Nucleotides cause pain by exciting and sensitizing
nociceptive neurons. While the duration of nucleotide
signaling can be limited by purinergic receptor desen-
sitization and nucleotide hydrolysis, it was unknown
how rapidly specific ectonucleotidases break down
nucleotides in any region of the nervous system. The
speed at which hydrolysis occurs could affect the bal-
ance between the excitatory effects of nucleotides and
the inhibitory effects of adenosine. While we pre-
viously found that PAP and NT5E were co-expressed
in nociceptive neurons and could hydrolyze AMP
[10,11], we did not previously show that either
enzyme could generate adenosine directly in nocicep-
tive circuits or how fast these enzymes generate ade-
nosine. Moreover, since our studies were focused on
Pap and Nt5e single knockout mice, we could not
predict a priori if these enzymes had redundant or
non-redundant functions.
To resolve these issues, we generated Pap/Nt5e dKO
mice–the first double knockout of any pair of ectonu-
cleotidases. Our analysis revealed that PAP and NT5E
together generate the majority of all adenosine from
AMP in nociceptive axon terminals. FSCV allowed us to
monitor the speed at which these ectonucleotidases gen-
erate adenosine. And, the small FSCV probes allowed us
to selectively monitor adenosine production in the
spinal microdomain where these enzymes are located.
To our surprise, we found that PAP and NT5E very
rapidly generate adenosine from pressure ejected AMP
and from endogenously released nucleotides.
Our conclusions are supported by an array of in vitro
and in vivo experiments. Indeed, we found that dKO
animals had pronounced deficits in hydrolyzing AMP to
adenosine, AMP ® adenosine-dependent antinocicep-
tion, and AMP ® adenosine-dependent synaptic inhibi-
tion. While a pH preference for these enzymes was
evident in histochemical and FSCV experiments, both
enzymes contribute additively to nucleotide hydrolysis
under physiologically relevant in vivo conditions (Figure
2). PAP and NT5E are likely to encounter wide extracel-
lular pH fluctuations under normal physiological and
pathological conditions. For example, excitatory
synapses become transiently acidified following gluta-
mate release [30], synaptic vesicle pH can reach pH 5.6
[31], and pathological conditions lead to prolonged acid-
ification and nucleotide release [32].
Our experiments also revealed that at least one more
adenosine-generating ectonucleotidase is present in
nociceptive circuits. This finding could not have been
predicted from studying Pap or Nt5e single knockouts,
and suggests nociceptive circuits have a highly redun-
dant molecular apparatus for eliminating nucleotides
while simultaneously generating adenosine. While defi-
nitive molecular identification of this third ectonucleoti-
dases is beyond the scope of our present study, our data
do provide genetic and biochemical clues as to what this
additional ectonucleotidase(s) might be. AMP hydrolysis
and adenosine production were largely eliminated in
lamina II at pH 5.6 in dKO mice, making it unlikely this
enzyme is another acid phosphatase. However, this
enzyme could have a neutral to alkaline pH optimum
given that adenosine is produced at pH 7.4 (albeit at
levels that are only ~30% of WT levels; Figure 2H).
Alkaline phosphatases are present in the spinal cord,
have such a pH optimum and can hydrolyze ATP, ADP
and AMP extracellularly [7,33]. Whether alkaline phos-
phatases (of which there are four functional genes in the
mouse) or other ectonucleotidases contribute to residual
adenosine production in spinal nociceptive circuits
remains to be determined.
FSCV allowed us to measure rapid changes in adeno-
sine concentration in a micron-sized region of spinal
Figure 6 A nucleoside transport inhibitor promotes the
buildup of ectonucleotidase-generated adenosine. (A) AMP was
pressure ejected into lamina II of WT spinal cord slices in the
absence or presence of DIP. FSCV was used to measure extracellular
adenosine. (B) Average responses ± s.e.m., from n = 3 slices. DIP
significantly increased the concentration of extracellular adenosine
from 0.7 to 8 s following AMP addition (P < 0.005 by one-way
ANOVA).
Street et al. Molecular Pain 2011, 7:80
http://www.molecularpain.com/content/7/1/80
Page 9 of 15
Figure 8 Inflammatory heat hyperalgesia and mechanical allodynia are enhanced in Pap-/-, Nt5e-/- and dKO mice. (A, B) WT, Pap-/-, Nt5e-/-
, and dKO mice were tested for (A) thermal and (B) mechanical sensitivity before (BL) and following injection of CFA (arrow) into one hindpaw.
The contralateral hindpaw served as control. All data are presented as means ± s.e.m. A repeated measures two-way ANOVA (P < 0.0005 for all
genotypes) with Bonferroni’s post-hoc test was used to compare WT to Pap-/-, Nt5e-/-, and dKO mice (n = 9-10 mice per group). *P < 0.05; **P <
0.005, ***P < 0.0005. There were no significant differences between dKO and Pap-/- or dKO and Nt5e-/- mice.
Figure 7 Dipyridamole, an adenosine transport blocker, gradually inhibits excitatory synaptic transmission in lamina II of WT mice but
not A1R or dKO mice. (A) Illustration depicting the placement of the suction electrode to stimulate fEPSPs and the recording electrode in
lamina II. (B1-B2) Representative Aδ fEPSPs in WT and A1R
-/- spinal cord slices before (BL; black) and 25 min after (red) addition of DIP (25 μM) to
the perfusate. (B3) Normalized fEPSP amplitude in WT and A1R
-/- spinal cord slices (n = 15, and 14 respectively, P < 0.001 by two-way ANOVA
and Bonferroni’s post-hoc tests). (C1-C3) Representative Aδ fEPSPs in Pap
-/-, Nt5e-/-, and dKO spinal cord slices before (black) and after (red)
addition of DIP (25 μM). (C4) Normalized fEPSP amplitude in Pap
-/-, Nt5e-/-, and dKO spinal cord slices (n = 13, 12 and 16 respectively). The
normalized fEPSP amplitude after DIP addition was significantly larger in dKO slices when compared to WT (P < 0.001 by two-way ANOVA and
Bonferroni’s post-hoc tests). There were no significant differences between WT and Pap-/- or WT and Nt5e-/- fEPSP amplitudes after DIP addition.
(B3, C4) Data are presented as means ± s.e.m.
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cord. The temporal and spatial resolution of this
method far surpasses all previously used methods for
measuring adenosine (including direct approaches like
enzyme bioprobes or microdialysis coupled with HPLC
and indirect approaches like quantifying signaling down-
stream of adenosine receptors) [18,19,23,24,27,34].
Unexpectedly, we detected spontaneous adenosine tran-
sients in spinal lamina II, the termination zone for noci-
ceptive afferents. This is the first time adenosine
transients were detected in any region of the nervous
system. The duration of these events was remarkably
short (lasting 1.5 ± 0.1 s on average in WT mice; Table
1), suggesting adenosine is rapidly generated/released
within lamina II, precisely where PAP and NT5E are
found [10,11]. Transients were detected in all WT slices
but only ~50% of all Pap-/-, Nt5e-/- and dKO slices. And,
within the subset of Pap-/-, Nt5e-/- and dKO slices where
transients were observed, the frequency of adenosine
transients was reduced by more than half. These data
strongly suggest that PAP and NT5E generate adenosine
transients in lamina II by rapidly hydrolyzing endogen-
ously released nucleotides. Rapid generation of adeno-
sine is consistent with ectonucleotidases being in close
proximity to nucleotide release sites [35].
Nucleotides like ATP are released from several cell types
by point-source burst release, which occurs spontaneously
at a low frequency (0.38 ± 0.18 bursts/min in rat astrocytes)
[1]. Intriguingly, adenosine transients occur at a similar fre-
quency (0.35 ± 0.04 events/min; Table 1), possibly reflect-
ing the pulsatile availability of nucleotide substrate. Several
distinct mechanisms of ATP release have been reported in
neurons, glia and other cell types, including from vesicles
(exocytosis), connexin 43 hemichannels, P2X7 ion channels
and volume activated anion channels [36-43]. Many of
these mechanisms are kinetically fast and Ca2+ dependent.
Future studies will be needed to determine which cells
release ATP and which molecular mechanisms underlie
nucleotide release in nociceptive circuits.
Our data also suggests it might be possible to dynami-
cally regulate adenosine transient frequency through
physiological and genetic factors. Indeed, we found ade-
nosine transients were reduced in frequency in WT
slices under zero Ca2+ conditions and in dKO slices;
however, transients did not disappear (Table 1). Simi-
larly, capsaicin-evoked adenosine release from synapto-
somes (isolated from dorsal spinal cord) was reduced in
Ca2+-free conditions and when nonselective ectonucleo-
tidase inhibitors were used [19]. Since adenosine transi-
ents were not eliminated in dKO mice, there must be
additional mechanisms underlying their generation.
These mechanisms could include: 1.) hydrolysis of extra-
cellular nucleotides by ectonucleotidase(s) other than
PAP and NT5E and/or 2.) direct release of adenosine
from cells, such as by exocytosis or reverse transport
through equilibrative nucleoside transporters [17,19].
Physiological significance of pulsatile adenosine
Our physiological and behavioral data suggest that ecto-
nucleotidases, and the adenosine transients they gener-
ate, endow nociceptive circuits with a way to transform
pulsatile or sustained nucleotide release into an inhibi-
tory adenosinergic signal. Notably, we found that transi-
ents were generated in all WT slices but only in ~50%
of all Pap-/-, Nt5e-/- and dKO slices, suggesting more
“failures” when ectonucleotidases are eliminated. More-
over, the frequency of these events was significantly
reduced in slices from all three mutant genotypes. The
failure to generate transients, combined with reduced
transient frequency likely explains why excitatory neuro-
transmission was not inhibited after treating dKO slices
with DIP (Figure 7). These data suggest that PAP and
NT5E generate adenosine endogenously at a level that is
sufficient to activate A1R and inhibit excitatory neuro-
transmission in lamina II. However, in the absence of
these enzymes, less adenosine is tonically produced,
causing unimpeded excitatory neurotransmission and
enhanced nociceptive responses.
In addition, adenosine transients and the enzymes that
generate these transients appear to be biochemically
“tuned” to dynamically activate A1R. In particular,
Table 2 Acute mechanical and thermal sensitivity
Behavioral Assay WT Pap-/- Nt5e-/- dKO
Withdrawal threshold:
Electronic von Frey 7.8 ± 0.3 g 7.8 ± 0.4 g 8.0 ± 0.2 g 8.0 ± 0.2 g
Withdrawal latency:
Radiant heating of hindpaw (Hargreaves Method) 9.9 ± 0.4 s 10.2 ± 0.4 s 10.6 ± 0.4 s 10.2 ± 0.4 s
Tail immersion at 46.5°C 16.9 ± 1.2 s 14.3 ± 0.7 s 12.6 ± 0.6 s** 13.1 ± 1.0 s*
Tail immersion at 49.0°C 7.2 ± 0.7 s 4.7 ± 0.2 s*** 4.0 ± 0.2 s*** 4.7 ± 0.3 s**
Hot plate at 52°C 33.5 ± 1.7 s 37.7 ± 2.6 s 29.6 ± 1.5 s 31.1 ± 2.2 s
Hot plate at 55°C 16.2 ± 1.1 s 13.5 ± 0.5 s 13.5 ± 1.1 s 12.7 ± 0.8 s*
Data are expressed as means ± s.e.m. One-way ANOVAs were performed with Bonferroni’s post hoc test to compare each genotype to WT. For post hoc tests, *P
< 0.05, **P < 0.005, ***P < 0.0005. n = 10 male mice tested per genotype.
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transients have a peak adenosine concentration of 530 ±
60 nM as measured by FSCV (Table 1), and could be
slightly higher given that analyte concentration is dis-
tance dependent with respect to its point of release/pro-
duction [44]. Extracellular adenosine concentration in
hippocampus was similarly ~300-1500 nM [28]. This
concentration range is remarkably similar to the concen-
tration range that half-maximally stimulates A1R (760
nM-3.1 μM) [45-47]. Since the peak adenosine concen-
tration of each transient falls within the most sensitive
region of the A1R dose-response curve, small increases
or decreases in transient frequency, especially when
integrated over time, could have profound effects on
A1R signaling. Indeed, excitatory potentials were inhib-
ited in an A1R-dependent manner only when PAP and
NT5E were both deleted (Figure 7), suggesting both
enzymes generate more adenosine over time than either
enzyme alone. Lastly, ectonucleotidases can “channel”
adenosine directly to A1R [48], which could further
maximize the signaling effects of enzymatically produced
adenosine.
Conclusions
Our data indicate that PAP and NT5E rapidly transform
nucleotides in nociceptive circuits into an inhibitory
adenosine tone that is pulsatile and subject to frequency
modulation. Ectonucleotidases are present and func-
tional throughout the brain [49]. These enzymes could
thus dynamically modulate diverse physiological and
pathological processes–like sleep, synaptic plasticity and
striatal motor function–that are under tonic adenosine
control [50,51].
Methods
Animals
All procedures and behavioral experiments involving
vertebrate animals were approved by the Institutional
Animal Care and Use Committee at the University of
North Carolina at Chapel Hill. Mice were raised under a
12:12 light:dark cycle and fed Prolab RMH 3000 (Lab-
Diet) ad libitum. C57BL/6 mice were purchased from
Jackson Laboratories or bred in house from C57BL/6J
stock. Pap-/- (Vihko et al., abstract from Proceedings of
the AACR, 2005, 96th Annual Meeting, Anaheim, CA)
[11], Nt5e-/-[52] and A1R
-/-[12] mice were backcrossed
to C57BL/6J mice for > 10 generations. dKO mice were
generated by breeding backcrossed Nt5e-/- and Pap-/-
mice.
Enzyme histochemistry
AMP histochemistry was performed as previously
described [10,11]. Briefly, adult male mice 6-12 weeks of
age were killed by decapitation. Lumbar spinal cord and
DRG were dissected and immersion fixed in 4%
paraformaldehyde in 0.1 M phosphate buffer at pH 7.4
(8 and 4 hours respectively). Tissue was cryoprotected
in 30% sucrose in 0.1 M phosphate buffer pH 7.3 at 4°C
for at least 24 hours. DRG and spinal cord were sec-
tioned (20 μm and 30 μm thick, respectively) on a cryo-
stat and were collected on Superfrost Plus slides (DRG)
or as free-floating sections (spinal cord). Enzyme histo-
chemistry was performed using 1 or 6 mM AMP as sub-
strate in Tris-maleate buffer at pH 5.6 or pH 7.0 with
2.4 mM lead nitrate. Staining intensity was quantified
using ImageJ as follows: a rectangle was drawn over
lamina II, then mean grey scale (a measure of pixel
intensity) was determined from multiple (7-10) images
from each genotype and averaged. We then took the
inverse of the mean pixel intensity and multiplied by
1000 so that larger numbers corresponded to darker
staining.
Behavior
Male mice, 2-4 months old, were acclimated to the test-
ing room, equipment and experimenter for 1-3 days
before behavioral testing. The experiments were carried
out during the light phase and the experimenter was
blind to the genotype during testing. The Hargreaves
method was used to test noxious thermal sensitivity.
One measurement was taken from each paw to deter-
mine withdrawal latency. The radiant heat source cutoff
time was 20 s. The tail-immersion assay and hot plate
test were carried out as previously described [10].
Mechanical sensitivity was measured using an electronic
von Frey apparatus (IITC) as described previously [11].
Three measurements were taken from each paw (sepa-
rated at 10 min. intervals) then averaged to determine
paw withdrawal threshold in grams. Complete Freund’s
adjuvant (20 μl CFA; MP Biomedicals) was injected into
one hindpaw, centrally beneath glabrous skin with a
30G needle. Adenosine 5’-monophosphate (AMP; 80
mM stock, Fluka 01930) and 5-iodotubericidin (ITU, 25
mM stock, Biomol, EI-293) were dissolved in 0.9% saline
and DMSO, respectively, and were then diluted in 0.9%
saline before use. Dipyridamole (DIP, 4 mM stock;
Sigma D9766) was dissolved in 0.9% saline slightly acidi-
fied with HCl as described [25]. All drugs were intrathe-
cally injected (5 μl) into unanethetized mice using the
direct lumbar puncture method.
Slice preparation
Transverse (800-900 μm, used in field recordings) and
sagittal (400 μm, used in FSCV experiments) spinal cord
slices were prepared as previously described from 1-2
month old mice [53]. Briefly, mice were anesthetized
with urethane (1.5 g/kg, i.p.) and the lumbar spinal cord
was quickly dissected and sliced on a Vibratome 3000EP
at 4°C. The dissection buffer contained the following (in
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mM): 87 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 75
sucrose, 10 glucose, 1.5 ascorbic acid, 0.5 CaCl2, 7
MgCl2. The slices were then incubated at 37°C for 45
minutes and then at room temperature in regular artifi-
cial cerebrospinal fluid (ACSF) that contained (in mM):
125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 25 glu-
cose, 2.5 CaCl2, 1.5 MgCl2. For cyclic voltammetry
experiments, the slices were incubated for one hour or
less before the experiments were carried out. All solu-
tions were bubbled with 95% O2/5% CO2 for the dura-
tion of the dissection and incubation steps.
Fast-scan cyclic voltammetry of adenosine
Disk-shaped carbon-fiber microelectrodes were fabri-
cated as previously described [54]. Briefly, a single 6 μm
diameter T-650 carbon fiber (Thornell, Amoco Corp.
Greenville, SC) was aspirated into a glass capillary (1.2
mm × 0.68 mm, AM Systems, Carlsborg, WA) which
was then sealed on a vertical pipette puller (model PE-
21, Narishige Group, Japan). Electrodes were then cut
with a surgical blade, sealed with epoxy, and polished at
30° on a K. T. Brown micro-pipette beveller (model BV-
10, Sutter Instruments, Novato, CA). Before use, electro-
des were soaked in a mixture of isopropanol and acti-
vated carbon for at least 20 minutes [55]. To detect
adenosine, the electrode’s potential was held at -0.4 V
between each scan, and was ramped from -0.4 V to 1.5
V at a scan rate of 400 V/s every 100 ms. The peak at
1.0 V was used to quantify the peak concentrations of
adenosine because it is unique to adenosine and not
observed with ATP, ADP or AMP [23]. An Ag/AgCl
reference electrode was used for all experiments.
FSCV data was collected using a custom LABVIEW
program, Tar Heel CV. Two computer interface boards
(National Instruments PCI 6052 and PCI 6711, Austin,
TX) were used to apply the triangular waveform, digitize
the resulting current, and to control pressure ejection
synchronization with the waveform application through
a homemade breakout box. A Chem-Clamp Voltam-
meter (Dagan Corporation, Minneapolis, MN) was used
to control the electrode potential and measure the
resulting current, which was filtered with a built-in ana-
log low pass Bessel filter at 10 kHz. To make electrical
contact with the head stage, a stainless steel wire was
inserted into the back of the microelectrode which was
backfilled with an electrolyte mixture of 4 M potassium
acetate and 0.15 M potassium chloride.
FSCV data were viewed in the form of color plots with
sequentially stacked cyclic voltammograms shown over
time (abscissa), plotted against the electrode potential
displayed on the ordinate where the switching potential
(1.5 V) is in the middle. The current is displayed in false
color, with oxidative currents being shown in green and
reductive currents being shown in blue and black. From
these plots, the current at a specific potential can be
plotted against time to examine how the adenosine con-
centration changes. These current traces are converted
to concentration from calibrations performed in a flow
injection apparatus which allows for a bolus of adeno-
sine ranging in concentration from 1-10 μM or 10 μM
AMP to be introduced to the electrode surface.
To detect the production of adenosine by PAP and
NT5E, 100 μM AMP was pressure ejected five times at
5 minute intervals using a Picospritzer® III (Parker
Instrumentation, Pinebrook, NJ) for 1 s at 20 psi from a
micropipette inserted into sagittal slices, approximately
100 μm from the carbon fiber microelectrode. To mini-
mize tissue damage, electrodes were inserted at 30° from
the slice surface with the disk facing down, approxi-
mately 50 μm below the surface of the slice. AMP solu-
tions were freshly prepared for each experiment to
overcome the possible confound of degradation into
adenosine. Furthermore, the absence of adenosine in the
pressure ejection pipette was confirmed before and after
each experiment by ejections onto the electrode above
the slice (confirmed by the absence of current at 1.0 V).
For experiments carried out at pH 5.6, five consecutive
ejections at 5 minute intervals were performed 10 min-
utes after application of pH 5.6 buffer. The buffer used
for experiments at pH 5.6 contained in mM: 10 Tris
Maleate, 140 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 5 Glucose,
and pH adjusted to 5.6 with NaOH. When detecting
spontaneous adenosine transients, the carbon fiber was
inserted into the slice without any stimuli applied to the
slice. For adenosine assignment, each event had a distin-
guishable cyclic voltammogram with a current peak at
1.0 V that was more than 5 times the standard deviation
of the baseline noise.
Field potential recordings
Transverse slices containing one dorsal root were placed
in the chamber and the root was suctioned into a glass
electrode in order to stimulate all sensory afferents.
Slices were maintained at room temperature and per-
fused with ACSF at 2 mL/min for the duration of the
recordings. Recording electrodes were pulled from boro-
silicate glass on a Sutter P-97 puller to a tip resistance
of 1-2 MΩ when filled with ACSF. Under visualization
of the slice under low (5X) magnification, the recording
electrode was placed in the medial portion of lamina II
(the substantia gelatinosa). The dorsal root was stimu-
lated for 0.5 msec at 5x the intensity needed to evoke a
maximal response. The root was stimulated once every
10 seconds (0.1 Hz) and every 6 signals were averaged
to give a single point for every minute of recording. The
resulting signals were filtered at 1 kHz, amplified 1000
times with a Multiclamp 700B amplifier, captured at 10
kHz with an Axon Digidata 1440A, and analyzed using
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pClamp 10 software (Molecular Devices). The waveform
observed was similar to fEPSPs recorded in transverse
rat spinal cord slices [29], with a distinguishable peak
that reportedly represents Aδ thinly myelinated affer-
ents, and delayed peaks that were broad and only
evoked with high intensity stimulation that likely repre-
sent a mixture of unmyelinated c-fiber afferents and
polysynaptic activity. DIP (25 mM stock in DMSO) was
added to the bath solution after 10 minutes of baseline
recording. Only one experiment was carried out per
slice. Experiments in which fEPSPs drifted more than
5% during the baseline recording period were not
analyzed.
Statistical Tests
Statistical analysis was carried out using Microsoft Excel,
and Graph Pad Prism software.
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